FIELD: medicine. SUBSTANCE: medical preparation has sea-buckthorn oil, hexapeptide having structural formula of arginine-alpha-aspartyl-lysyl-valyl-thyrosyl-arginine, suppository base and glycine in known proportions of ingredients. EFFECT: enhanced effectiveness in treating oncological and hematological patients; wide range of pharmacological properties. 2 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR COPING WITH STEROID RESISTANCE | 2009 |
|
RU2404792C1 |
| METHOD OF TREATING PATIENTS WITH LICHEN PLANUS | 2014 |
|
RU2564907C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
| AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
| SUPPOSITORIES FOR TREATING HEMORRHOID, PROCTITIS AND OTHER PROCTOLOGIC INFLAMMATIONS | 2013 |
|
RU2545994C1 |
| PROCTOLOGICAL SUPPOSITORIES | 2000 |
|
RU2157185C1 |
| ADHESIVE OINTMENT FOR TREATING ORAL MUCOSAL INVOLVEMENTS IN LICHEN ACUMINATUS | 2012 |
|
RU2508120C1 |
| AGENT FOR EXTERNAL APPLICATION, POSSESSING ANTIVIRAL ACTIVITY | 2006 |
|
RU2338553C2 |
| PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY, IMMUNOCORRECTING, IMMUNOSUPPRESSIVE, ANTIVIRAL, ANTI-INFLAMMATORY AND ONCOLYTIC ACTIVITIES | 2021 |
|
RU2775008C1 |
| METHOD OF POTENTIATION OF MEDICINAL AGENT CURATIVE EFFECT | 1997 |
|
RU2104032C1 |
